Form4insider filings, from the source

SEC Form 4 · accession 0001209191-17-041951

bluebird bio, Inc. · BLUE

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Daniel Lynch
Director
Period of report
Jun 23, 2017
Accepted (ET)
Jun 27, 2017 · 4:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001293971

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockJun 23, 2017M2,008$2.0864A4,808D
Common StockJun 23, 2017M1,992$5.5004A6,800D
Common StockF2Jun 23, 2017S2,200$108.2896D4,600D
Common StockF3Jun 23, 2017S1,000$109.74D3,600D
Common StockF4Jun 23, 2017S800$110.4813D2,800D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (right to buy)F5$2.0864Jun 23, 2017M2,008D—Jul 31, 2021Common Stock2,0080D
Stock Option (right to buy)F6$5.5004Jun 23, 2017M1,992D—Jan 16, 2023Common Stock1,99223,842D

Explanation of responses